Sharenet Sites 
Sharenet Sites
Middle East Site Visit
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
Mediclinic International Middle East Site Visit
Mediclinic International plc (“Mediclinic” or the “Company”), a leading international private healthcare
group, is today hosting a two day site visit of its Middle East platform. The event will be hosted by
David Hadley, Chief Executive Officer of Mediclinic Middle East, and will include visits to several of
the platform’s hospitals and clinics in Abu Dhabi and Dubai, in addition to presentations on the
Company’s Middle East operations.
No new trading or financial information will be disclosed. Copies of the presentations will be made
available on the Company’s website: www.mediclinic.com
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information please contact:
Mediclinic International
Gert Hattingh, Executive Group Services
+27 (0)21 809 6500
Bell Pottinger
Liz Morley/Aarti Iyer/Lucy Stewart
+44 (0)203 772 2468
Notes:
Mediclinic is the world's third largest listed acute hospital operator (outside of the United States), with
three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United
Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing cost-effective
acute care specialised hospital services. The group operates 73 hospitals and 45 clinics.
Mediclinic also holds a 29.9% interest in Spire Healthcare, a LSE-listed private healthcare group
based in the UK.
15 June 2016
Date: 15/06/2016 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
